SOLIGENIX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period
SOLIGENIX, INC. (SNGX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period of 1.00 million shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod · last filed 2020-03-30
- SOLIGENIX, INC. share-based compensation arrangement by share-based payment award, options, other increases (decreases) in period for fiscal 2019 was 1.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period 12 month |
|---|---|
| 2019-12-31 | 1.00M shares 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |